Analyzing Complement Activity

Controlling the complement system is essential for studying immune responses and creating therapies for complement-related diseases. By using activators or inhibitors, researchers can either stimulate or suppress the system’s response. With tools like antibodies and ELISA kits, you can study and influence this system in detail.

Precision Tools for Targeted Therapeutics

In the expanding field of complement therapeutics, the demand for more precise quantitative methods is increasing. Since the approval of early complement-targeting drugs like C1-INH and Eculizumab (anti-C5), the number of clinical candidates in development has surged. Complement therapeutics, once focused on rare diseases, now extend to areas like autoimmunity, neurodegenerative disorders, cancer biology, and kidney transplantation. These treatments are no longer confined to the terminal complement pathway but also aim for targeted intervention within the classical and alternative pathways.

What do we offer?

We offer pathway-specific inhibitory compounds that can be customized to your needs, along with reagents that are easily accessible for experimental use, unlike restricted pharmaceutical compounds. Here is an overview of all a careful selection research tools to investigate complement inhibition or activation.

Classical pathway specific

Alternative pathway specific

Terminal pathway specific

Activity tests